Valuation Agenus Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-16 EDT			5-day change	1st Jan Change
6.040 ^USD	-9.58%		-21.25%	+92.36%

10-08	Agenus Gets Armenia Approval for Botensilimab-Balstilimab Combination	MT
10-08	Agenus Inc. Receives Marketing Authorizations in Armenia for Botvymo and Evamplix for Use in Combination in Previously Treated Mss Metastatic Colorectal Cancer	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	827	731.5	315.8	64.28	106.8	271.9	-	-
Change	-	-11.54%	-56.83%	-79.65%	66.13%	154.64%	-	-
Enterprise Value (EV)	827	731.5	315.8	64.28	106.8	271.9	271.9	271.9
Change	-	-11.54%	-56.83%	-79.65%	66.13%	154.64%	0%	0%
P/E	-29.3x	-3.08x	-1.2x	-0.26x	-	24.5x	-12.8x	-13x
PBR	-	-	-	-	-	-	-	-
PEG	-	-0x	0.1x	0x	-	-	0x	7.39x
Capitalization / Revenue	2.8x	7.46x	2.02x	0.62x	0.94x	2.17x	2.34x	2.11x
EV / Revenue	0x	0x	0x	0x	0x	2.17x	2.34x	2.11x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	0x	-0x	-0x	-0x	-0x	5.13x	10.3x	-71.6x
EV / FCF	-0x	-0x	-0x	-0x	-0x	-5.43x	-12.2x	-5.69x
FCF Yield	-2.86%	-31.2%	-74.1%	-247%	-72.3%	-18.4%	-8.2%	-17.6%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.2	-15.6	-13.8	-10.59	-	0.2467	-0.4733	-0.465
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	295.7	98.02	156.3	103.5	114.2	125.2	116	129.1
EBITDA	-	-154.1	-	-	-	-	-	-
EBIT ¹	25.75	-179.4	-159.5	-124.4	-20.17	53	26.4	-3.8
Net income ¹	-24.14	-230.7	-257.4	-232.3	-0.101	39.4	-28.55	-53.55
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	64.400	48.000	16.558	2.740	3.140	6.040	6.040	6.040
Nbr of stocks (in thousands)	12,842	15,241	19,075	23,459	34,008	45,020	-	-
Announcement Date	3/1/22	3/14/23	3/14/24	3/11/25	3/16/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
AGENUS INC.	24.49x	-	-	-	272M
WUXI APPTEC CO., LTD.	18.75x	6.69x	13.41x	1.58%	65B
LONZA GROUP AG	35.3x	6.27x	18.74x	0.92%	51.2B
ARGENX SE	27.56x	7.53x	23.83x	0.05%	51.19B
IQVIA HOLDINGS INC.	34.01x	3.32x	14.33x	-.--%	43.93B
BEONE MEDICINES AG	48.9x	5.59x	30.73x	-.--%	41.96B
REVOLUTION MEDICINES, INC.	-18.47x	189.62x	-19.51x	-.--%	38.14B
CELLTRION, INC.	28.97x	8.21x	21.25x	0.37%	33.24B
WUXI BIOLOGICS (CAYMAN) INC.	29.19x	6.17x	16.01x	-.--%	25.2B
GENMAB A/S	30.74x	5.69x	19.09x	-.--%	22.5B
Average	25.94x	26.57x	15.32x	0.32%	37.26B
Weighted average by Cap.	25.96x	25.01x	15.48x	0.44%